{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:14:52Z","timestamp":1791519292629,"version":"4.3.4"},"reference-count":30,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14604","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T10:29:58Z","timestamp":1722421798000},"source":"Crossref","is-referenced-by-count":2,"title":["Characteristics of sphingomyelin metabolism in the MCF7 and BT474 radiotherapy\u2011resistant HER2\u2011positive breast cancer cell lines"],"prefix":"10.3892","volume":"28","author":[{"given":"Megumi","family":"Kikuchi","sequence":"first","affiliation":[{"name":"Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Monzen","sequence":"additional","affiliation":[{"name":"Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Horikoshi","sequence":"additional","affiliation":[{"name":"Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuri","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yota","family":"Tatara","sequence":"additional","affiliation":[{"name":"Department of Stress Response Science, Center for Advanced Medical Research, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036\u20118562, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wojcik","sequence":"additional","affiliation":[{"name":"Department of Molecular Biosciences, The Wenner\u2011Gren Institute, Stockholm University, Stockholm, Stockholm SE\u201110691, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Mariya","sequence":"additional","affiliation":[{"name":"Department of Radiology, Aomori Rosai Hospital, Hachinohe, Aomori 031\u20110822, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"key20240906090818_b1-ol-28-4-14604","article-title":"Cancer Today- Age-Standardized Rate (World) per 100 000, Incidence, Both sexes, in 2022","author":"International Agency for Research on Cancer"},{"key":"key20240906090818_b2-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20240906090818_b3-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"key20240906090818_b4-ol-28-4-14604","article-title":"Cancer Information Service, National Cancer Center, Japan. (Survival)","author":"Cancer Registry and Statistics"},{"key":"key20240906090818_b5-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.3390\/cancers13215350","article-title":"Molecular classification of breast cancer utilizing long non-coding RNA (lncRNA) transcriptomes identifies novel diagnostic lncRNA panel for triple-negative breast cancer","volume":"13","author":"Shaath","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20240906090818_b6-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/annonc\/mds286","article-title":"Human epidermal growth factor receptor-2-positive breast cancer: Does estrogen receptor status define two distinct subtypes?","volume":"24","author":"Vaz-Luis","year":"2013","journal-title":"Ann Oncol"},{"key":"key20240906090818_b7-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"852748","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: Overexpression and therapeutic implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Mol Biol Int"},{"key":"key20240906090818_b8-ol-28-4-14604","article-title":"ERBB2 erb-b2 receptor tyrosine kinase 2 [Homo sapiens (human)] Gene ID: 2064","author":"National Center for Biotechnology Information"},{"key":"key20240906090818_b9-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3892\/mco.2020.2140","article-title":"HER2-positive breast cancer that resists therapeutic drugs and ionizing radiation releases sphingomyelin-based molecules to circulating blood serum","volume":"13","author":"Monzen","year":"2020","journal-title":"Mol Clin Oncol"},{"key":"key20240906090818_b10-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"807636","DOI":"10.3389\/fonc.2021.807636","article-title":"The role of sphingolipids metabolism in cancer drug resistance","volume":"11","author":"Bataller","year":"2021","journal-title":"Front Oncol"},{"key":"key20240906090818_b11-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/biot.200700169","article-title":"Statistical methods for efficiency adjusted real-time PCR quantification","volume":"3","author":"Yuan","year":"2008","journal-title":"Biotechnol J"},{"key":"key20240906090818_b12-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20240906090818_b13-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3-new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"key20240906090818_b14-ol-28-4-14604","first-page":"136","article-title":"Radiobiology for the Radiologist","author":"Hall","year":"2000","edition":"5th edition"},{"key":"key20240906090818_b15-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1007\/s00018-016-2130-4","article-title":"The DNA damage-induced cell death response: A roadmap to kill cancer cells","volume":"73","author":"Matt","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"key20240906090818_b16-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"675","DOI":"10.15171\/apb.2018.076","article-title":"Streptomyces levis ABRIINW111 Inhibits SW480 cells growth by apoptosis induction","volume":"8","author":"Maragheh","year":"2018","journal-title":"Adv Pharm Bull"},{"key":"key20240906090818_b17-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.3390\/cancers13122922","article-title":"Targeting mTOR and glycolysis in HER2-positive breast cancer","volume":"13","author":"Holloway","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20240906090818_b18-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.1158\/1078-0432.CCR-12-1436","article-title":"HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells","volume":"18","author":"Duru","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20240906090818_b19-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"45186","DOI":"10.18632\/oncotarget.9870","article-title":"HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo","volume":"7","author":"Hou","year":"2016","journal-title":"Oncotarget"},{"key":"key20240906090818_b20-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1038\/s41467-020-18245-7","article-title":"Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells","volume":"11","author":"Candas-Green","year":"2020","journal-title":"Nat Commun"},{"key":"key20240906090818_b21-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13014-019-1268-2","article-title":"Development and characterisation of acquired radioresistant breast cancer cell lines","volume":"14","author":"Gray","year":"2019","journal-title":"Radiat Oncol"},{"key":"key20240906090818_b22-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1667\/RR1472.1","article-title":"NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance","volume":"171","author":"Cao","year":"2009","journal-title":"Radiat Res"},{"key":"key20240906090818_b23-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00432-013-1494-1","article-title":"Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society","volume":"140","author":"Duru","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20240906090818_b24-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.4161\/cbt.8.24.10131","article-title":"Targeting HER2 signaling pathway for radiosensitization: Alternative strategy for therapeutic resistance","volume":"8","author":"No","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"key20240906090818_b25-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.plipres.2013.05.001","article-title":"Biological functions of sphingomyelins","volume":"52","author":"Slotte","year":"2013","journal-title":"Prog Lipid Res"},{"key":"key20240906090818_b26-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3389\/fphar.2019.00443","article-title":"Sphingomyelin synthase 1 (SMS1) downregulation is associated with sphingolipid reprogramming and a worse prognosis in melanoma","volume":"10","author":"Bilal","year":"2019","journal-title":"Front Pharmacol"},{"key":"key20240906090818_b27-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41419-019-1303-0","article-title":"Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin","volume":"10","author":"Zheng","year":"2019","journal-title":"Cell Death Dis"},{"key":"key20240906090818_b28-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"16104","DOI":"10.1038\/s41598-022-20050-9","article-title":"Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-\u03b2\/ALK5 inhibitor","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"key":"key20240906090818_b29-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13046-023-02605-4","article-title":"LARP6 suppresses colorectal cancer progression through ZNF267\/SGMS2-mediated imbalance of sphingomyelin synthesis","volume":"42","author":"Long","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"key20240906090818_b30-ol-28-4-14604","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.dib.2018.04.081","article-title":"Data on metabolomic profiling of ovarian cancer patients' serum for potential diagnostic biomarkers","volume":"18","author":"Kozar","year":"2018","journal-title":"Data Brief"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:08:24Z","timestamp":1725602904000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7,31]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14604","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"article-number":"471"}}